{"AllianceGenome": "3767", "HGNC": "3767", "MIM": "136352", "_id": "2324", "_version": 1, "accession": {"genomic": ["AC122714.2", "CH471165.2", "CP068273.2", "CS067238.1", "CS172288.1", "CS172403.1", "CS172817.1", "CS172819.1", "DQ911346.1", "HC040608.1", "HC040723.1", "JQ664717.1", "JQ664718.1", "JQ664719.1", "KM210556.1", "KM210557.1", "KM484807.1", "KM484808.1", "KM484809.1", "KM484810.1", "KM484811.1", "KM484812.1", "KM484813.1", "KM484814.1", "KM484815.1", "KM484816.1", "KM484817.1", "KM484818.1", "KM484819.1", "KM484820.1", "KP684481.1", "KP684482.1", "KP684483.1", "KP684484.1", "KP684485.1", "KP684486.1", "KP684487.1", "KT584348.1", "NC_000005.10", "NC_060929.1", "NG_011536.1"], "protein": ["AAA85215.1", "AAB28539.1", "AAO89504.1", "AAO89505.1", "ACF47600.1", "ACF47601.1", "ACF47602.1", "AFN73242.1", "AFN73243.1", "AFN73244.1", "AIU34641.1", "AIU34642.1", "AIY55328.1", "AIY55329.1", "AIY55330.1", "AIY55331.1", "AIY55332.1", "AIY55333.1", "AIY55334.1", "AIY55335.1", "AIY55336.1", "AIY55337.1", "AIY55338.1", "AIY55339.1", "AIY55340.1", "AKN45935.1", "AKN45936.1", "AKN45937.1", "AKN45938.1", "AKN45939.1", "AKN45940.1", "AKN45941.1", "BAD92874.1", "BAF84368.1", "CAA48290.1", "CAA49505.1", "CAI84582.1", "CAJ32888.1", "CAJ32905.1", "CAJ33671.1", "CAJ33685.1", "CBH30507.1", "CBH30547.1", "EAW53749.1", "EAW53750.1", "NP_001341918.1", "NP_002011.2", "NP_891555.2", "P35916.3", "XP_011532780.1", "XP_011532786.1", "XP_016864752.1", "XP_016864755.1", "XP_016864757.1", "XP_047272958.1", "XP_047272959.1", "XP_054208150.1", "XP_054208151.1", "XP_054208152.1", "XP_054208153.1", "XP_054208154.1", "XP_054208155.1", "XP_054208156.1"], "rna": ["AB209637.1", "AK291679.1", "AK309910.1", "AY233382.1", "AY233383.1", "BC027302.1", "CA438330.1", "DB455035.2", "EU826564.1", "EU826565.1", "EU826566.1", "NM_001354989.2", "NM_002020.5", "NM_182925.5", "S66407.1", "U43143.1", "X68203.1", "X69878.1", "XM_011534478.4", "XM_011534484.3", "XM_017009263.2", "XM_017009266.2", "XM_017009268.2", "XM_047417002.1", "XM_047417003.1", "XM_054352175.1", "XM_054352176.1", "XM_054352177.1", "XM_054352178.1", "XM_054352179.1", "XM_054352180.1", "XM_054352181.1"], "translation": [{"protein": "NP_891555.2", "rna": "NM_182925.5"}, {"protein": "XP_054208153.1", "rna": "XM_054352178.1"}, {"protein": "XP_054208154.1", "rna": "XM_054352179.1"}, {"protein": "XP_054208156.1", "rna": "XM_054352181.1"}, {"protein": "AAA85215.1", "rna": "U43143.1"}, {"protein": "AAB28539.1", "rna": "S66407.1"}, {"protein": "ACF47600.1", "rna": "EU826564.1"}, {"protein": "BAF84368.1", "rna": "AK291679.1"}, {"protein": "XP_054208155.1", "rna": "XM_054352180.1"}, {"protein": "XP_016864752.1", "rna": "XM_017009263.2"}, {"protein": "XP_016864755.1", "rna": "XM_017009266.2"}, {"protein": "AAO89504.1", "rna": "AY233382.1"}, {"protein": "NP_001341918.1", "rna": "NM_001354989.2"}, {"protein": "BAD92874.1", "rna": "AB209637.1"}, {"protein": "XP_016864757.1", "rna": "XM_017009268.2"}, {"protein": "XP_054208152.1", "rna": "XM_054352177.1"}, {"protein": "XP_054208150.1", "rna": "XM_054352175.1"}, {"protein": "XP_047272959.1", "rna": "XM_047417003.1"}, {"protein": "CAA49505.1", "rna": "X69878.1"}, {"protein": "ACF47601.1", "rna": "EU826565.1"}, {"protein": "NP_002011.2", "rna": "NM_002020.5"}, {"protein": "XP_011532786.1", "rna": "XM_011534484.3"}, {"protein": "XP_054208151.1", "rna": "XM_054352176.1"}, {"protein": "CAA48290.1", "rna": "X68203.1"}, {"protein": "XP_047272958.1", "rna": "XM_047417002.1"}, {"protein": "XP_011532780.1", "rna": "XM_011534478.4"}, {"protein": "AAO89505.1", "rna": "AY233383.1"}, {"protein": "ACF47602.1", "rna": "EU826566.1"}]}, "alias": ["CHTD7", "FLT-4", "FLT41", "LMPH1A", "LMPHM1", "PCL", "VEGFR-3", "VEGFR3"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": [{"classification": "definitive", "classification_date": "2022-12-19T17:00:00.000Z", "disease_label": "lymphatic malformation 1", "gcep": "Prenatal Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0007919", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_623ef8f5-43ba-43e2-9c2d-fd44e87d6946-2022-12-19T170000.000Z", "sop": "SOP9"}, {"classification": "definitive", "classification_date": "2023-03-08T17:00:00.000Z", "disease_label": "congenital heart defects, multiple types, 7", "gcep": "Prenatal Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0032913", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_03e5cbf0-2888-4416-bb0f-85909fc297ce-2023-03-08T170000.000Z", "sop": "SOP10"}]}, "ec": "2.7.10.1", "ensembl": {"gene": "ENSG00000037280", "protein": ["ENSP00000261937", "ENSP00000377016", "ENSP00000421535", "ENSP00000426057", "ENSP00000481134"], "transcript": ["ENST00000261937", "ENST00000393347", "ENST00000424276", "ENST00000502293", "ENST00000502603", "ENST00000502649", "ENST00000507059", "ENST00000510000", "ENST00000512795", "ENST00000513527", "ENST00000514810", "ENST00000619105"], "translation": [{"protein": "ENSP00000261937", "rna": "ENST00000261937"}, {"protein": "ENSP00000377016", "rna": "ENST00000393347"}, {"protein": "ENSP00000426057", "rna": "ENST00000502649"}, {"protein": "ENSP00000481134", "rna": "ENST00000619105"}, {"protein": "ENSP00000421535", "rna": "ENST00000512795"}], "type_of_gene": "protein_coding"}, "entrezgene": "2324", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 49.1670994536, "exp_mis": 623.194657841, "exp_syn": 334.427820656, "lof_z": 6.23952142428977, "mis_z": 3.72651592395529, "mu_lof": 3.6203630871e-06, "mu_mis": 5.87785706668e-05, "mu_syn": 3.10033155968e-05, "n_lof": 5.0, "n_mis": 433.0, "n_syn": 330.0, "p_li": 0.999936678740361, "p_null": 4.31714994113817e-15, "p_rec": 6.33212596345212e-05, "syn_z": 0.150101924046617}, "bp": 4092, "cds_end": 180076545, "cds_start": 180030191, "n_exons": 30, "nonpsych": {"exp_lof": 43.9361880702, "exp_mis": 563.486537181, "exp_syn": 302.124673812, "lof_z": 6.06524264828693, "mis_z": 3.60126457944447, "mu_lof": 3.6203630871e-06, "mu_mis": 5.87785706668e-05, "mu_syn": 3.10033155968e-05, "n_lof": 3.0, "n_mis": 394.0, "n_syn": 304.0, "p_li": 0.999985549062865, "p_null": 3.51722868461684e-15, "p_rec": 1.44509371311188e-05, "syn_z": -0.0679267923052983}, "nontcga": {"exp_lof": 45.1786816905, "exp_mis": 573.284075372, "exp_syn": 307.6185628, "lof_z": 6.04347744033724, "mis_z": 3.62645755844838, "mu_lof": 3.6203630871e-06, "mu_mis": 5.87785706668e-05, "mu_syn": 3.10033155968e-05, "n_lof": 4.0, "n_mis": 399.0, "n_syn": 305.0, "p_li": 0.999948061867581, "p_null": 1.31398846784313e-14, "p_rec": 5.19381324054399e-05, "syn_z": 0.0945333669307495}, "transcript": "ENST00000261937.6"}, "exons": [{"cdsend": 180649545, "cdsstart": 180608131, "chr": "5", "position": [[180607748, 180608159], [180608967, 180609053], [180609904, 180610025], [180611330, 180611479], [180612505, 180612611], [180613010, 180613110], [180614067, 180614179], [180616366, 180616489], [180616899, 180616994], [180618769, 180618920], [180619020, 180619109], [180619252, 180619366], [180619664, 180619769], [180620172, 180620308], [180620608, 180620715], [180620875, 180621007], [180621105, 180621252], [180621541, 180621904], [180622730, 180622839], [180623934, 180624061], [180625868, 180626031], [180626110, 180626265], [180628881, 180628999], [180629258, 180629427], [180629695, 180629835], [180629942, 180630105], [180630224, 180630337], [180630554, 180630799], [180631681, 180631778], [180649487, 180649600]], "strand": -1, "transcript": "NM_001354989", "txend": 180649600, "txstart": 180607748}, {"cdsend": 180649545, "cdsstart": 180608280, "chr": "5", "position": [[180607748, 180608284], [180608967, 180609053], [180609904, 180610025], [180611330, 180611479], [180612505, 180612611], [180613010, 180613110], [180614067, 180614179], [180616366, 180616489], [180616899, 180616994], [180618769, 180618920], [180619020, 180619109], [180619252, 180619366], [180619664, 180619769], [180620172, 180620308], [180620608, 180620715], [180620875, 180621007], [180621105, 180621252], [180621541, 180621904], [180622730, 180622839], [180623934, 180624061], [180625868, 180626031], [180626110, 180626265], [180628881, 180628999], [180629258, 180629427], [180629695, 180629835], [180629942, 180630105], [180630224, 180630337], [180630554, 180630799], [180631681, 180631778], [180649487, 180649600]], "strand": -1, "transcript": "NM_002020", "txend": 180649600, "txstart": 180607748}, {"cdsend": 180649545, "cdsstart": 180603191, "chr": "5", "position": [[180601505, 180603390], [180608967, 180609053], [180609904, 180610025], [180611330, 180611479], [180612505, 180612611], [180613010, 180613110], [180614067, 180614179], [180616366, 180616489], [180616899, 180616994], [180618769, 180618920], [180619020, 180619109], [180619252, 180619366], [180619664, 180619769], [180620172, 180620308], [180620608, 180620715], [180620875, 180621007], [180621105, 180621252], [180621541, 180621904], [180622730, 180622839], [180623934, 180624061], [180625868, 180626031], [180626110, 180626265], [180628881, 180628999], [180629258, 180629427], [180629695, 180629835], [180629942, 180630105], [180630224, 180630337], [180630554, 180630799], [180631681, 180631778], [180649487, 180649600]], "strand": -1, "transcript": "NM_182925", "txend": 180649600, "txstart": 180601505}], "exons_hg19": [{"cdsend": 180076545, "cdsstart": 180035131, "chr": "5", "position": [[180034748, 180035159], [180035967, 180036053], [180036904, 180037025], [180038330, 180038479], [180039505, 180039611], [180040010, 180040110], [180041067, 180041179], [180043366, 180043489], [180043899, 180043994], [180045769, 180045920], [180046020, 180046109], [180046252, 180046366], [180046664, 180046769], [180047172, 180047308], [180047608, 180047715], [180047875, 180048007], [180048105, 180048252], [180048541, 180048904], [180049730, 180049839], [180050934, 180051061], [180052868, 180053031], [180053110, 180053265], [180055881, 180055999], [180056258, 180056427], [180056695, 180056835], [180056942, 180057105], [180057224, 180057337], [180057554, 180057799], [180058681, 180058778], [180076487, 180076600]], "strand": -1, "transcript": "NM_001354989", "txend": 180076600, "txstart": 180034748}, {"cdsend": 180076545, "cdsstart": 180035280, "chr": "5", "position": [[180034748, 180035284], [180035967, 180036053], [180036904, 180037025], [180038330, 180038479], [180039505, 180039611], [180040010, 180040110], [180041067, 180041179], [180043366, 180043489], [180043899, 180043994], [180045769, 180045920], [180046020, 180046109], [180046252, 180046366], [180046664, 180046769], [180047172, 180047308], [180047608, 180047715], [180047875, 180048007], [180048105, 180048252], [180048541, 180048904], [180049730, 180049839], [180050934, 180051061], [180052868, 180053031], [180053110, 180053265], [180055881, 180055999], [180056258, 180056427], [180056695, 180056835], [180056942, 180057105], [180057224, 180057337], [180057554, 180057799], [180058681, 180058778], [180076487, 180076600]], "strand": -1, "transcript": "NM_002020", "txend": 180076600, "txstart": 180034748}, {"cdsend": 180076545, "cdsstart": 180030191, "chr": "5", "position": [[180028505, 180030390], [180035967, 180036053], [180036904, 180037025], [180038330, 180038479], [180039505, 180039611], [180040010, 180040110], [180041067, 180041179], [180043366, 180043489], [180043899, 180043994], [180045769, 180045920], [180046020, 180046109], [180046252, 180046366], [180046664, 180046769], [180047172, 180047308], [180047608, 180047715], [180047875, 180048007], [180048105, 180048252], [180048541, 180048904], [180049730, 180049839], [180050934, 180051061], [180052868, 180053031], [180053110, 180053265], [180055881, 180055999], [180056258, 180056427], [180056695, 180056835], [180056942, 180057105], [180057224, 180057337], [180057554, 180057799], [180058681, 180058778], [180076487, 180076600]], "strand": -1, "transcript": "NM_182925", "txend": 180076600, "txstart": 180028505}], "generif": [{"pubmed": 11807987, "text": "A potential mechanism involved in hemangioma formation is the alteration of the FLT4 signaling pathway in endothelial and/or pericytic cells."}, {"pubmed": 11877295, "text": "VEGF-C signaling through FLT-4 (VEGFR-3) mediates leukemic cell proliferation, survival, and resistance to chemotherapy."}, {"pubmed": 12048269, "text": "Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling."}, {"pubmed": 12168824, "text": "Vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C are expressed in human colorectal adenocarcinoma."}, {"pubmed": 12393704, "text": "generation of endothelial cells from CD34+ cells is associated with expression of VEGFR3 on the cell surface"}, {"pubmed": 12819011, "text": "Data demonstrate the expression of vascular endothelial growth factor receptor-3 and vascular endothelial growth factor-C on corneal dendritic cells, which implicate a potential relationship between lymphangiogenesis and leukocyte trafficking in the eye."}, {"pubmed": 12881528, "text": "the carboxyl-terminal tail of VEGFR-3 provides important regulatory tyrosine phosphorylation sites with potential signal transduction capacity and these sites are differentially used in ligand-induced homo- and heterodimeric receptor complexes"}, {"pubmed": 14558949, "text": "VEGF-C/flt-4 system can promote vasculogenesis in stroma of breast cancer. The number of Flt-4 positive vessels is closely related to lymph node metastasis."}, {"pubmed": 14687619, "text": "Specific VEGFR3 expression, examined in 27 B-CLL samples, was positive in 26 of them. The VEGF transduction pathway may be very active in CLL cells. Both its paracrine & autocrine pathways may contribute to their enhanced survival."}, {"pubmed": 14760756, "text": "VEGF-C and its receptor FLT-4 play a role in the development of gastric cancer, and the tumors with expression of VEGF-C and FLT-4 are more likely to have lymph node metastasis."}, {"pubmed": 15102829, "text": "VEGFR-3 may protect against oxidative damage in endothelial cells, and that patients with hereditary lymphoedema may be susceptible to ROS-induced cell damage."}, {"pubmed": 15107801, "text": "expression levels were significantly elevated in primary prostatic tumors with sentinel lymph node involvement compared to those lacking lymph node involvement"}, {"pubmed": 15297417, "text": "vascular endothelial growth factor receptor-3 may have a role in lymph node metastasis in prostate cancer"}, {"pubmed": 15389531, "text": "integrin alpha5beta1 participates in the activation of both VEGFR-3 and its downstream PI3 kinase/Akt signaling pathway, which is essential for fibronectin-mediated lymphatic endothelial cell survival and proliferation."}, {"pubmed": 15474514, "text": "VEGFR-3 needs to be associated to VEGFR-2 to induce ligand-dependent cellular responses"}, {"pubmed": 15693535, "text": "Patients with primary lymphedema have serum level of VEGF-D significantly higher than controls.The increased levels of VEGF-D suggest that primary lymphedema may be based on defective stimulation of VEGFR-3."}, {"pubmed": 15746084, "text": "Ang1 has a role in lymphatic vessel endothelial proliferation, Tie2 expression, and VEGFR-3 upregulation"}, {"pubmed": 15878864, "text": "KSHV gB can activate VEGFR-3 on the microvascular endothelium and modulate endothelial cell migration and proliferation via an interaction between the alpha3beta1 integrin and the VEGFR-3 receptor"}, {"pubmed": 15880525, "text": "increased expression of VEGF-C and VEGFR-3 play a role in prostate cancer progression and in metastasis to regional lymph nodes"}, {"pubmed": 16044920, "text": "There was a close correlation between the expressions of VEGFR-3, CD31 and prostate tumor metastases."}, {"pubmed": 16116610, "text": "Overexpression of vascular endothelial growth factor receptor 3 is associated with lung adenocarcinoma"}, {"pubmed": 16375119, "text": "VEGF-C and its receptor FLT-4 play an important role in the lymphatic metastasis of laryngeal and hypopharyngeal squamous cell carcinoma."}, {"pubmed": 16525637, "text": "VEGFR-3/flt4 was expressed in cancer stromal cells."}, {"pubmed": 16624815, "text": "VEGF-D/VEGFR-3 signaling plays a critical role in osteoblast maturation"}, {"pubmed": 16755294, "text": "The VEGF-3/VEGFR-c ratio was positively associated with lymph node metastasis in non-small cell lung cancer ."}, {"pubmed": 16959214, "text": "multiple myeloma cells (but not B-cell chronic lymphocytic leukemia cells) induced a dramatic increase in expression of VEGFR-1 and VEGFR-3 on human bone marrow endothelial cells"}, {"pubmed": 17088944, "text": "These results suggest that the expression of VEGFRs and NRPs on keratinocytes may constitute important regulators for its activity and may possibly be responsible for the autocrine signaling in the epidermis."}, {"pubmed": 17458866, "text": "This is the first report of an exon 22 mutation of VEGFR3 in Milroy disease."}, {"pubmed": 17487423, "text": "VEGFR-3 may play a role in the abnormal endometrial angiogenesis of idiopathic menorrhagia."}, {"pubmed": 17539024, "text": "expression of VEGFR-3(S) is up-regulated in >75% of hepatitis B x antigen positive hepatocellular carcinoma (HCC) nodules; HBxAg may short circuit VEGFR-3(S) signaling in liver cancer"}, {"pubmed": 17597103, "text": "Both VEGF-A and angiopoietin-2 upregulated the expression of VEGFR-3 in cultured lymphatic endothelial cells"}, {"pubmed": 17686546, "text": "In non-small-cell lung cancer cells, VEGF-C/VEGFR-3 coexpression suggests an autocrine/paracrine loop responsible for a high proliferation rate in tumour cells."}, {"pubmed": 17761831, "text": "interaction of CEACAM1 with Prox1 and VEGFR-3 plays a crucial role in tumor lymphangiogenesis and reprogramming of vascular endothelial cells to lymphatic endothelial cells"}, {"pubmed": 17926187, "text": "Expression of VEGF-C, VEGF-D and their receptor VEGFR-3 in diffuse large B-cell lymphomas."}, {"pubmed": 17935478, "text": "data suggest that VEGF-C alters lymphatic endothelial function through a mechanism involving VEGFR-3"}, {"pubmed": 17945164, "text": "the spectrum of the VEGFR-3 gene mutations causing HL-I"}, {"pubmed": 17948123, "text": "Data demonstrate that Notch1 and VEGFR-3 interact genetically, that Notch directly induces VEGFR-3 in blood endothelial cells to regulate vascular development, and that Notch and VEGF signaling may function in tumor lymphangiogenesis."}, {"pubmed": 18006056, "text": "Increased expression of VEGFR-3 is associated with acute myeloid leukaemia"}, {"pubmed": 18008346, "text": "VEGFR-3 was expressed in malignant cells from different subtypes of MM"}, {"pubmed": 18094729, "text": "VEGFR3 single nucleotide polymorphisms andthe haplotype GC in the VEGFA gene are associated with psoriasis in Koreans"}, {"pubmed": 18212541, "text": "Three of the 4 Retiform hemangioendothelioma (RH) biopsies failed to demonstrate D2-40, none expressed VEGFR-3...RH is a vascular entity which usually does not have lymphatic differentiation, but may rarely express D2-40."}, {"pubmed": 18279219, "text": "The present study identified 2 novel VEGFR3 mutations in Japanese families with Milroy's disease."}, {"pubmed": 18292935, "text": "Under hypoxic conditions an autocrine loop between VEGF-C/VEGFR-3 and HIF-1 alpha is possible in breast carcinoma and lung carcinoma but not in colorectal carcinoma cell lines."}, {"pubmed": 18307927, "text": "The high expressions of VEGF-C/VEGFR-3 and inactivation of nm23-H(1) may play an important role in lymphatic metastasis in oral squamous cell carcinoma."}, {"pubmed": 18440723, "text": "Report expression of VEGF-C/VEGFR3 in osteosarcomas."}, {"pubmed": 18538738, "text": "VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors."}, {"pubmed": 18538739, "text": "Provide further evidence that VEGF-C/VEGFR-3 are expressed and function in cancer cells."}, {"pubmed": 18561194, "text": "VEGF-C and VEGF-D expressions were associated with VEGFR-3 expression and were significantly correlated with both peritumoral lymphangiogenesis and lymph node metastasis."}, {"pubmed": 18564920, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18594512, "text": "results implicate VEGFR-3 as a regulator of vascular network formation"}, {"pubmed": 18642643, "text": "No association was detected between the Single Nucleotide Polymorphism in the Vascular Endothelial Growth Factor and susceptibility to hemifacial spasm."}, {"pubmed": 18719607, "text": "G933R and D1049N mutations in tyrosine kinase domains of FLT4 in Nonne-Milroy lymphadema"}, {"pubmed": 18829111, "text": "VEGFR-1/-3 co-expression is associated with high hemoglobin level in childhood acute lymphoblastic leukemia"}, {"pubmed": 18973153, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19002718, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19002718, "text": "prevalence of VEGFR3 mutations in patients with primary lymphoedema"}, {"pubmed": 19039941, "text": "Reduced secretion of VEGF and expression of VEGF-R3 by placental endothelial cells in gestosis can be caused by functional deficiency of the endothelial cells and low viability of endothelial cells."}, {"pubmed": 19066962, "text": "The expression of VEGF-A, VEGFR-1, VEGFR-2, and VEGFR-3 in was higher in peritumoral liver tissue, while VEGF-C expression was higher in tumor."}, {"pubmed": 19068081, "text": "High VEGFR-3 in stromal vessels is associated with gastric cancer."}, {"pubmed": 19099632, "text": "As2O3 can inhibit expression of VEGF-C and VEGFR-3 of human gastric cancer xenografts in nude mice."}, {"pubmed": 19151999, "text": "VEGFR-3 was detected in 43 of 58 (72%) cavernous lymphangiomas, 20 of 28 (71%) cystic hygromas, six of 12 (50%) lymphangiomas circumscriptum, and seven of ten (70%) intraabdominal lymphangiomas"}, {"pubmed": 19240177, "text": "High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with small cell lung cancer."}, {"pubmed": 19289394, "text": "study showed that hypomorphic VEGFR3 mutations can cause recessive primary congenital lymphoedema"}, {"pubmed": 19301310, "text": "TGFbeta1 stimulates VEGFD/VEGFR3 receptor axis activation leading to increased cell migration and invasion by primary intermediate prostate cancer basal cell cultures"}, {"pubmed": 19394045, "text": "Mutations in the VEGFR3 and FOXC2 genes account for a subset of patients with unexplained in utero generalized subcutaneous edema and hydrops fetalis without family history of lymphedema"}, {"pubmed": 19556880, "text": "VEGFR-3 overexpression promotes breast cancer cell proliferation, motility, survival, anchorage-independent growth and tumorogenicity in the absence of ligand expression."}, {"pubmed": 19628565, "text": "co-expression of PDGF-B and VEGFR-3 is strongly associated with poor survival in NSCLC patients."}, {"pubmed": 19636022, "text": "Phase I dose escalation study of telatinib, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor 2 and 3, platelet-derived growth factor receptor beta, and c-Kit, in patients with advanced or metastatic solid tumors."}, {"pubmed": 19701853, "text": "The nuclear localization of VEGF-C and its receptor Flt-4 is a novel finding from this study. It was more common in follicular than in peripheral T-cell or diffuse large-cell lymphomas. High Flt4 correlated with disseminated disease."}, {"pubmed": 19706680, "text": "Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells."}, {"pubmed": 19779139, "text": "The VEGF-C/FLT-4 autocrine loop in tumor cells was a potential enhancer system to promote cancer progression."}, {"pubmed": 19787226, "text": "High endothelial VEGFR-3 expression in colorectal carcinomas is associated with hematogenous metastasis."}, {"pubmed": 19813623, "text": "There is a close relationship of laryngeal squamous cell carcinomas with the expression of VEGF-C and VEGFR-3."}, {"pubmed": 19900702, "text": "Stimulation of trophoblasts (BeWo cells) with gal-1 showed a significant alteration of phosphorylation status in 3 receptor tyrosine kinases: JAK2, RET and VEGFR3. Phosphorylation of these kinases could be involved in gal-1-induced cell differentiation."}, {"pubmed": 19901262, "text": "Prox1 synergizes with the p50 of NF-kappaB to control VEGFR-3 expression."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19924384, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 19940551, "text": "Data show that tumor spheroid cells express ABCG2, Bmi1, WNT5A, CD133, prox1 and VEGFR3."}, {"pubmed": 20182906, "text": "Clinical trial of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20223440, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20224550, "text": "Both VEGFA and VEGFC potently induce formation of VEGFR2/-3 heterodimers."}, {"pubmed": 20237496, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20431062, "text": "Cell adhesion to extracellular matrix induces a downstream signaling using the tyrosine kinase receptor VEGFR-3 as scaffold."}, {"pubmed": 20452482, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20555004, "text": "The herein described case, which is the third reported so far with c.3109G>C mutation, adds data on genotypic-phenotypic correlation of Milroy disease"}, {"pubmed": 20606037, "text": "The upregulation of VEGFR-3 on tumor blood vessels indicates a potential additional antiangiogenic effect for dual VEGFR-2/VEGFR-3-targeted therapy."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20673868, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20949568, "text": "High-level MYC amplification was found in 100% of secondary Angiosarcoma (AS), but in none of the AVL or other radiation-associated sarcomas. Coamplification of FLT4 (encoding VEGFR3) was identified in 25% of secondary AS, but not in other types."}, {"pubmed": 21163065, "text": "VEGFR-3 expression was correlated with histological grade, lymph node status and distant metastasis, but not correlated with gender, age, location, tumor size and TNM staging of papillary renal cell carcinoma."}, {"pubmed": 21179485, "text": "VEGFR-3 is a strong and independent negative prognostic marker for non-GIST STSs with wide resection margins"}, {"pubmed": 21269982, "text": "The correlation between VEGFR-3 and the Gleason score was high in prostate cancer."}, {"pubmed": 21635552, "text": "findings show VEGFR-2 and VEGFR-3 expression are markers of a poor prognosis in patients with surgically resected colorectal adenocarcinoma, whereas EGFR has a minor influence"}, {"pubmed": 21680174, "text": "RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways."}, {"pubmed": 21751212, "text": "Data show that normal thyroid follicular cells express VEGFRs 1, 2, and 3."}, {"pubmed": 21805024, "text": "The recombinant lentivirus particles were able to remarkably suppress VEGFR-3 expression, regulate the cell cycle, inhibit proliferation and induce apoptosis in the MKN45 cell lines."}, {"pubmed": 21839498, "text": "the effects of vegfc/VEGFR3 on the progression of tumor cells to form lymph node metastases occur primarily under an hypoxic tumor microenvironment."}, {"pubmed": 21909098, "text": "Macrophage-derived VEGF-C activates VEGFR-3 in tip cells to reinforce Notch signalling, which contributes to the phenotypic conversion of endothelial cells at fusion points of vessel sprouts."}, {"pubmed": 21912471, "text": "LYVE-1, VEGFR-3 and CD44 all play an important role in lymphangiogenesis, invasion and metastasis"}, {"pubmed": 21972089, "text": "Strong expression of VEGF-C and VEGFR-3 in gastrointestinal stromal tumors was not correlated with the clinical parameters of aggressiveness, nor with high lymphatic vessel density."}, {"pubmed": 22016416, "text": "VEGF-A plays a role in the occurrence of OHSS, and the amount of biologically available VEGF-A is modulated by sVEGF-R1, R2 and R3"}, {"pubmed": 22179834, "text": "Studies indicate that Vascular endothelial growth factor-C (VEGF-C) and VEGF receptor 3 signaling are essential for the development of lymphatic vessels and is a promising target for inhibition of tumor lymphangiogenesis."}, {"pubmed": 22223733, "text": "Suggest that miR-1236 may function as a negative regulator of VEGFR-3 signaling during inflammatory lymphangiogenesis."}, {"pubmed": 22326635, "text": "A significant relationship was found in salivary gland tumors with myoepithelial differentiation regarding simultaneous positive staining for VEGF-C/VEGF-D and flt-4"}, {"pubmed": 22366442, "text": "VEGFR3 is involved in the induction of lymphangiogenesis which results in lymphatic spread of nasopharyngeal carcinoma."}, {"pubmed": 22404826, "text": "Single nucleotide polymorphisms in VEGFR3 gene is associated with lymphedema after breast cancer."}, {"pubmed": 22502683, "text": "High VEGFR-3 gene expression is associated with lymphatic metastasis in laryngeal squamous cell carcinomas."}, {"pubmed": 22512651, "text": "Binding of VEGF-C and endostatin to recombinant VEGFR-3 is competitive."}, {"pubmed": 22542663, "text": "results demonstrate that the proteolytic enzyme MMP-9 promotes resistant epithelial breast cancer cells migration and tubular network formation through VEGFR-2/ VEGFR-3 activation"}, {"pubmed": 22745786, "text": "Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis."}, {"pubmed": 22797697, "text": "Data suggest a regulatory role for VEGFR-3 in megakaryopoiesis."}, {"pubmed": 22819208, "text": "ELISA for the quantification of sVEGFR-3 in human plasma was validated and applied in clinical trials."}, {"pubmed": 22844119, "text": "K14-VEGFR-3-Ig transgenic mice lack dermal lymphatic capillaries and experience markedly depressed transport of dendritic cells from the skin to draining lymph nodes."}, {"pubmed": 22910845, "text": "The present findings suggest the potential role of VEGF-C in the pathogenesis and development of a pterygium through lymphangiogenesis and the VEGF-C/VEGFR-3 pathway as a novel therapeutic target for the human pterygium."}, {"pubmed": 22946664, "text": "malignant and stromal cells express high levels of VEGFR-3 in all stages of MF."}, {"pubmed": 22961441, "text": "NRP2 and VEGFR-3 mRNA levels were significantly higher in some of the vascular malformations endothelial cells."}, {"pubmed": 22965194, "text": "The expression of VEGFR-3 and its ligands, VEGF-C and VEGF-D, significantly increased after activating ET(B)R by ET-1 in primary and metastatic melanoma cell lines"}, {"pubmed": 23038639, "text": "VEGF-D and VEGFR-3 expression was significantly higher in benign prostate tissue compared to tumor in the stroma and the endothelium of lymphatic and blood vessels."}, {"pubmed": 23059885, "text": "The commitment of Prox1 positive cells through a lymphatic lineage is an early event for cervical neoplastic progression, being present starting with intraepithelial cervical lesions, and is strongly associated with VEGFR3 and VEGF-C expression."}, {"pubmed": 23059888, "text": "VEGFR-1, VEGFR-2 and VEGFR-3 are expressed in both fetal and adult bone. The gene expression levels were significantly higher in fetal samples especially in mandibles. In addition, higher levels of VEGFR-3 in orofacial district were confirmed."}, {"pubmed": 23074044, "text": "Studies indicate that variants in the VEGFR3 (FLT4) gene, encoding vascular endothelial growth factor receptor 3 (VEGFR3), were identified as being responsible for the majority of Milroy disease (MD)."}, {"pubmed": 23336661, "text": "Shh, Gli1, VEGFC, and VEGFR3 expression was higher in colorectal adenocarcinoma than in normal mucosa. Gli1 expression correlated with VEGFC and VEGFR3 expression but not lymphatic metastasis."}, {"pubmed": 23404187, "text": "this data suggest a relationship between VEGFR-3 and IFN-gamma expression in NK cells."}, {"pubmed": 23490417, "text": "The rs10085109 single nucleotide polymorphism in the FLT4 gene were associated with susceptibility to atopic dermatitis."}, {"pubmed": 23552426, "text": "Ets-1 is a novel regulator of VEGFR3 and is involved in the induction of angiogenic phenotypes by KSHV."}, {"pubmed": 23580180, "text": "study investigated the expression of VEGFR-1, VEGFR-3 and caveolin-1 molecules in 183 colorectal cancer tissue specimens and explored their effect in both clinicopathological parameters and disease prognosis"}, {"pubmed": 23591595, "text": "unlike an anti-VEGFR-3 Mab (mF4-31C1), DC101 was not capable of eliminating either tumor lymphangiogenesis or lymphogenous metastasis (60 % reduction of lymph node metastasis by DC101 vs 95 % by mF4-31C1)."}, {"pubmed": 23614535, "text": "Lymph node and lung metastases of HEC1A cells were completely suppressed by the muscle-mediated expression of sVEGFR-3."}, {"pubmed": 23737988, "text": "Expression of VEGF-C, VEGFR-1, and VEGFR-3 in peritumoral liver tissue is associated with a unique type of HCC that has a poorer outcome after hepatectomy"}, {"pubmed": 23803010, "text": "Data suggest that circulating VEGFR3/CD34 are biomarkers for epithelial ovarian cancer (EOC); circulating bone marrow-derived lymphatic/vascular endothelial progenitor cells are significantly increased in EOC and correlate with lymph node metastasis."}, {"pubmed": 23878260, "text": "Data indicate that mutation of the conserved residues mediating the D5 interaction (Thr446 and Lys516) and the D7 interaction (Arg737) compromised VEGF-C induced VEGFR-3 activation."}, {"pubmed": 23939705, "text": "Transwell assays revealed that VEGF-C receptor, VEGFR-3, as well as chemokine CCL21 receptor, CC chemokine receptor 7 (CCR7), were responsible for the migration of PC3 cells toward hypoxia preconditioned MSCs"}, {"pubmed": 24040410, "text": "increased expression in tumors of Ang-2 may individually, or in combination with VEGFR-3, predict poor prognosis of OSCC"}, {"pubmed": 24085575, "text": "Increase of VEGFR3 protein expression is associated with oral squamous cell carcinoma."}, {"pubmed": 24184958, "text": "probe F2 facilitated the identification of the target spectrum of the two inhibitors confirming many of the previously identified (off-) targets such as AURKA, FLT4-VEGFR3, IKBKE and PDGFRbeta."}, {"pubmed": 24341227, "text": "The expression of VEGF and its receptors (VEGFR-1, VEGFR-2 and VEGFR-3) was ascertained to be increased in the placental terminal and stem villi, mostly in type 1 diabetes."}, {"pubmed": 24398987, "text": "VEGF-C and VEGFR-3 expression was significantly higher in luminal A subtype compared to luminal B."}, {"pubmed": 24508126, "text": "These findings suggest that the VEGFC/VEGFR3 pathway acts as an enhancer of ovarian cancer progression"}, {"pubmed": 24650367, "text": "Data suggest that VEGFC (vascular endothelial growth factor C) enhances cervical cancer invasiveness via up-regulation of galectin-3 via stimulation of NFkappaB/RELA pathway; galectin-3 interacts/activates VEGFR3."}, {"pubmed": 24710631, "text": "A novel GC-rich element (GRE) spanning -101/-66 sufficient for VEGFR3 transcription and activated by Sp1 and Sp3, respectively, was identified."}, {"pubmed": 24713547, "text": "In primary ovarian cancer tissue, VEGFR3 expression, detected with an frequency of 26%, was mostly located in the vascular wall and across the stroma."}, {"pubmed": 24754736, "text": "analysis of how VEGF, VEGFR3, and PDGFRB protein expression is influenced by RAS mutations in medullary thyroid carcinoma"}, {"pubmed": 24845798, "text": "The expressions of VEGF-A, VEGFR2 and VEGFR3 were studied in by immunohistochemistry in 76 endometrial carcinoma specimens. VEGFR2 and VEGFR3 receptor expression were also studied by qRT-PCR in 17 tumors in comparison to normal endometrium."}, {"pubmed": 24858271, "text": "Expression of VEGFR-3 was highly correlated with tumor metastasis in prostate cancer patients."}, {"pubmed": 24982366, "text": "The CXCL12-CXCR4 axis may influence the expression of VEGFR3 in urothelial bladder carcinoma and promote tumor recurrence."}, {"pubmed": 25109169, "text": "Case Report: FLT4 missense mutation in Milroy disease."}, {"pubmed": 25229256, "text": "TNFR1 has a role in mediating TNF-alpha-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling"}, {"pubmed": 25281926, "text": "VEGF-C down-regulates VEGFR-3 in lymphatic endothelial cells"}, {"pubmed": 25329517, "text": "The results show that VEGFR1-VEGFR2 levels are more closely coupled than VEGFR1-VEGFR3 or VEGFR2-VEGFR3 in HUVEC and MEC."}, {"pubmed": 25340839, "text": "VEGFR family members are expressed in leiomyosarcomas in vivo and in vitro. Upon receptor stimulation, PTK787 is able to inhibit subsequent phosphorylation events and influences cell survival but not metabolic activity and migration"}, {"pubmed": 25399804, "text": "the best characterized of these signaling pathways, that involving the vascular endothelial growth factor (VEGF) family members VEGF-C and VEGF-D, together with their receptors VEGFR2 and VEGFR3."}, {"pubmed": 25524775, "text": "VEGFR3 lymphatic endothelium signaling involves regulation of AKT activation via VEGFR3/VEGFR2/neuropilin 1 complex, ERK via VEGFR3/R3 homodimer, as well as regulatory roles of VE-PTP."}, {"pubmed": 25543087, "text": "Neuropilin-2 mediates lymphangiogenesis of colorectal carcinoma via a VEGFC/VEGFR3 independent signaling."}, {"pubmed": 25605009, "text": "Genistein suppresses FLT4 and inhibits human colorectal cancer metastasis."}, {"pubmed": 25643397, "text": "Experiments in mice and zebrafish demonstrate that changing levels of VEGFR3/Flt4 modulates aortic lumen diameter consistent with flow-dependent remodeling"}, {"pubmed": 25667475, "text": "High CD31 expression associated significantly with better survival and VEGFR3 had no association with survival. Both higher tumor grade and stage were associated with a decreased survival time"}, {"pubmed": 25864386, "text": "Although MYC is a valuable ancillary tool in distinguishing angiosarcomas from atypical vascular lesions , FLT4 immunohistochemistry may be used to screen for patients with FLT4 gene amplification"}, {"pubmed": 25891418, "text": "These findings suggest that IL-8 may be a potent inducer of LECs, although this effect does not appear to involve the VEGF-C/VEGF-D and VEGFR-3 signaling pathway."}, {"pubmed": 25896638, "text": "Missense mutations in VEGFR3 confirmed Milroy disease in two unrelated patients."}, {"pubmed": 25909285, "text": "Data indicate that foretinib suppresses angiogenesis and lymphangiogenesis by blocking vascular endothelial growth factor receptors"}, {"pubmed": 26091405, "text": "A Novel Missense Mutation in FLT4 Causes Autosomal Recessive Hereditary Lymphedema"}, {"pubmed": 26091406, "text": "our findings contribute to the putative targets in which the FLT4 gene mutation was found to have a significant role in lymphatic filariasis, while FOXC2 and FLT4 SNP interactions need to be further elucidated at a functional level."}, {"pubmed": 26121315, "text": "VEGFR-3 is a new target to improve net ultrafiltration in methylglyoxal-induced peritoneal injury by suppressing lymphatic absorption"}, {"pubmed": 26394830, "text": "High expression levels of VEGFR1 and VEGFR3 were associated with a higher rate of lung metastasis."}, {"pubmed": 26476536, "text": "Data indicate that vascular endothelial growth factor D (VEGF-D) was the best indicator of metastasis and vascular endothelial growth factors and receptor-3 (VEGFR-3) may help to determine the prognosis and management of colorectal cancer (CRC)."}, {"pubmed": 26543080, "text": "MTA1 is up-regulated in CRC; its expression is inversely associated with lymphatic metastases and the expression of VEGFC, VEGFD and VEGFR3"}, {"pubmed": 26706909, "text": "The most extensively accepted signaling pathways promoting lymphangiogenesis in tumors include the secreted lymphangiogenic proteins: VEGF-C and VEGF-D, and their cognate receptor on lymphatic endothelium VEGF receptor-3 (VEGFR-3)."}, {"pubmed": 26714373, "text": "Case Reports: novel FLT4 gene mutation in a Chinese family with Milroy disease."}, {"pubmed": 26735859, "text": "Report FLT4 genetic alterations in angiosarcomas."}, {"pubmed": 27066737, "text": "this study uncovers a unique molecular mechanism of lymphangiogenesis in which galectin-8-dependent crosstalk among VEGF-C, podoplanin and integrin pathways plays a key role."}, {"pubmed": 27199372, "text": "By treating LECs with VEGF-C156S and analyzing subsequent changes in gene expression, we identified several 'immediate early' transcription factors that showed a rapid transient upregulation VEGFR-3 stimulation.  these results reveal an important and unanticipated role of HOXD10 in the regulation of VEGFR-3 signaling in lymphatic endothelial cells, and in the control of lymphangiogenesis and permeability."}, {"pubmed": 27527412, "text": "The summarizes the structure and function features of pathway-related molecules of VEGFC/D-VEGFR3/NRP2 axis, stages of various tumors and their molecular mechanisms and significances in tuthe expression changes of these molecules in different anatomic organs or histopathologic types or development lymphatic metastasis."}, {"pubmed": 27666723, "text": "This study suggests that NRP1 expression and LVD are independent factors that are likely to predict the risk of LN metastasis in squamous cell carcinoma (SCC)of the tongue, whereas the expression of VEGFC, VEGFR3, CCR7, and SEMA3E are nonindependent predictive factors"}, {"pubmed": 27837630, "text": "Assessment of VEGFR-2/VEGFR-3 on tumor samples might serve as a putative prognostic factor in renal cell carcinoma cases, identifying a subset of patients that may benefit from antiangiogenic treatments targeting VEGFR receptors."}, {"pubmed": 28163024, "text": "These results indicate that VEGF-C-induced MSC osteogenesis is mediated through VEGFR2 and VEGFR3, and followed the activation of the ERK/RUNX2 signaling pathway."}, {"pubmed": 28356442, "text": "There was a significant decrease in VEGFR3 expression in pulmonary arterial endothelial cells from pulmonary arterial hypertension patients."}, {"pubmed": 28447586, "text": "The results imply a very good sensitivity of VEGFR-3 in ESCC. VEGFR-3 may be a good diagnostic biomarker for ESCC."}, {"pubmed": 28508400, "text": "Vascular endothelial growth factor receptor 3 is a novel marker differing CD138-positive and CD138-negative multiple myeloma cells."}, {"pubmed": 28680264, "text": "the difference between the pro- (VEGF165a) and antiangiogenic (VEGF165b) VEGF isoforms and its soluble receptors for severity of diabetic retinopathy, is reported."}, {"pubmed": 28718364, "text": "The normalized methylation values for the VEGFR1, VEGFR2 and VEGFR3 promoters tended to be higher in the tumour cell lines than in normal tonsil samples, whereas amounts of VEGFR1, VEGFR2 and VEGFR3 messenger RNA were significantly higher"}, {"pubmed": 28791841, "text": "Data show that VEGF-C, VEGF-D, and VEGFR-3 were expressed in a substantial percentage of breast carcinomas."}, {"pubmed": 28939099, "text": "VEGFR-3 expression was associated with depth of invasion and lymph node metastasis in gastric cancer"}, {"pubmed": 28991257, "text": "Rare inherited and de novo variants in 2,871 congenital heart disease probands identified GDF1, MYH6, and FLT4 as causative genes."}, {"pubmed": 29122006, "text": "VEGFR3 single nucleotide polymorphisms association with lymphedema caused by Wuchereria bancrofti."}, {"pubmed": 29557990, "text": "VEGFR-3 and CAV3 expression demonstrated immunohistochemically in SMCs of the tunica media of SV grafts predicted their early restenosis in triple-vessel CAD patients. CAV2 protein expression in SMCs of ITA grafts indicated the risk of early graft failure both in double-vessel and triple-vessel CAD subjects."}, {"pubmed": 29615616, "text": "VEGFR3 has a role in lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms"}, {"pubmed": 29649427, "text": "activator of G-protein signaling 8 regulated the trafficking of VEGFR-3 to the plasma membrane"}, {"pubmed": 29777777, "text": "MiR-128-3p directly targets VEGFC/VEGFR3 to modulate the proliferation of lymphatic endothelial cells through Ca(2+) signaling"}, {"pubmed": 29787601, "text": "Single nucleotide polymorphism of VEGFR3 is associated with relapse in gastroenteropancreatic neuroendocrine neoplasms."}, {"pubmed": 29896974, "text": "novel mutation associated with Milroy disease was identified in a Chinese family"}, {"pubmed": 29908552, "text": "The finding of rare LAMA5 variants together with FLT4 in Milroy disease suggests that these mutations may be co-responsible for these disorders and most likely interfere with the function of lymphatics."}, {"pubmed": 30123080, "text": "study reveals that VEGFR-3 positive expression in tumors represents an independent prognostic factor for both overall and recurrence-free survival in hepatic resected patients with iCCA. VEGFR-3 positive tumors favor lymph node metastasis, tumor recurrence and worse outcomes through tumor-associated lymphangiogenesis."}, {"pubmed": 30169892, "text": "Study reports a novel c.2515G>C (p.E839Q) missense mutation located within the cytoplasmic domain in exon 17 of VEGFR3/FLT4 associated with a novel missense mutation, c.218T>C (p.L73P), located within the N-terminal propeptide in exon 2 of VEGF-C in familial Milroy disease."}, {"pubmed": 30232381, "text": "Loss-of-function variants in FLT4 and KDR contribute substantially to the genetic basis of tetralogy of Fallot (TOF).  The findings support dysregulated VEGF signaling as a novel mechanism contributing to the pathogenesis of TOF."}, {"pubmed": 30431105, "text": "Results indicated that VEGFR3 levels that were upregulated by HIF1alpha expression promoted human lymphatic endothelial cells colony formation and migration."}, {"pubmed": 30456868, "text": "These results suggest functional interactions among ATX, VEGFR-2, and VEGFR-3 in the modulation of hemovascular and lymphovascular cell activation during vascular development."}, {"pubmed": 30483911, "text": "In this study, a potential link between the FLT4 gene and OHSS has been suggested. Future functional studies are essential to define a more precise involvement of the detected variants in the development of OHSS."}, {"pubmed": 30518533, "text": "Data indicate that ILK facilitates mechanosensitive VEGFR3 signaling and physiologic lymph vessel expansion by controlling beta1 integrin-mediated VEGFR3 activation."}, {"pubmed": 30586762, "text": "results demonstrate a novel role for ARRB1 in VEGFR regulation and suggest a mechanism for cross talk between G protein-coupled receptors and VEGFRs in pulmonary arterial hypertension."}, {"pubmed": 30863410, "text": "Inflammation and Lymphatic Function."}, {"pubmed": 31013538, "text": "The Roles of Neuropilin 2/VEGF-C Axis in a Series of Recurrent Lymphangioma."}, {"pubmed": 31239267, "text": "The prolymphangiogenic factor VEGFC is abundant in colorectal cancer and activates VEGFR3 present on cancer-associated macrophages and lymphatic vessels; activation of VEGFR3 signaling fosters cancer immune escape, resulting in enhanced tumor growth."}, {"pubmed": 31878999, "text": "High expression of VEGFR3 in the lung adenocarcinoma tissue is positively correlated with poor prognosis."}, {"pubmed": 32160452, "text": "Can VEGFR-3 be a better tumor marker for breast cancer than CA 15-3?"}, {"pubmed": 32382040, "text": "PKCtheta-JunB axis via upregulation of VEGFR3 expression mediates hypoxia-induced pathological retinal neovascularization."}, {"pubmed": 32544090, "text": "S1PR1 regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress-dependent VEGF-C signaling."}, {"pubmed": 32616416, "text": "Morphometric image analysis of vascular endothelial growth factor receptor-3 in preeclamptic, HIV infected women."}, {"pubmed": 32618346, "text": "Vascular Endothelial Growth Factor Receptor-3 Expression Predicts Sentinel Node Status in Primary Cutaneous Melanoma."}, {"pubmed": 33191789, "text": "High ELK3 expression is associated with the VEGF-C/VEGFR-3 axis and gastric tumorigenesis and enhances infiltration of M2 macrophages."}, {"pubmed": 33446503, "text": "An immunohistochemical study of lymphatic elements in the human brain."}, {"pubmed": 34681005, "text": "FLT4 Mutations Are Associated with Segmental Lymphatic Dysfunction and Initial Lymphatic Aplasia in Patients with Milroy Disease."}, {"pubmed": 34918882, "text": "Determination of serum vascular endothelial growth factor (VEGF) and VEGF receptor levels with VEGF gene polymorphisms in patients with Behcet's uveitis."}, {"pubmed": 34994518, "text": "Resequencing of VEGFR3 pathway genes implicate GJC2 and FLT4 in the formation of primary congenital chylothorax."}, {"pubmed": 35339191, "text": "Knockdown of FLT4, Nup98, and Nup205 Cellular Genes Effectively Suppresses the Reproduction of Influenza Virus Strain A/WSN/1933 (H1N1) In vitro."}, {"pubmed": 36064450, "text": "ADSCs stimulated by VEGF-C alleviate intestinal inflammation via dual mechanisms of enhancing lymphatic drainage by a VEGF-C/VEGFR-3-dependent mechanism and inhibiting the NF-kappaB pathway by the secretome."}, {"pubmed": 36336681, "text": "PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation."}, {"pubmed": 36496429, "text": "A novel stop-gain pathogenic variant in FLT4 and a nonsynonymous pathogenic variant in PTPN11 associated with congenital heart defects."}, {"pubmed": 36538874, "text": "Two novel variations p.(Ser1275Thr) and p.(Ser1275Arg) in FLT4 causing prenatal hereditary lymphedema type 1."}, {"pubmed": 36835014, "text": "High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer."}, {"pubmed": 36922713, "text": "VEGFR3 suppression through miR-1236 inhibits proliferation and induces apoptosis in ovarian cancer via ERK1/2 and AKT signaling pathways."}, {"pubmed": 37317880, "text": "FLT4 as a marker for predicting prognostic risk of refractory acute myeloid leukemia."}, {"pubmed": 37454290, "text": "VEGFR3 is required for button junction formation in lymphatic vessels."}, {"pubmed": 38269589, "text": "Profibrotic VEGFR3-Dependent Lymphatic Vessel Growth in Autoimmune Valvular Carditis."}, {"pubmed": 38518198, "text": "The pathological roles and potential mechanisms of vascular endothelial growth factor receptor-3 in gastric cancer."}, {"pubmed": 38581027, "text": "Association study of FLT4 and HYDIN single nucleotide polymorphisms with atrial septal defect susceptibility in the Han Chinese population of Southwest China."}, {"pubmed": 38728943, "text": "miR-455-3p regulates lymphangiogenesis in silicosis by regulating VEGF-C/VEGFR3."}], "genomic_pos": {"chr": "5", "end": 180649624, "ensemblgene": "ENSG00000037280", "start": 180601506, "strand": -1}, "genomic_pos_hg19": {"chr": "5", "end": 180076624, "start": 180028506, "strand": -1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0001525", "qualifier": "involved_in", "term": "angiogenesis"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0001934", "pubmed": [11532940, 19779139], "qualifier": "involved_in", "term": "positive regulation of protein phosphorylation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0001938", "pubmed": 11532940, "qualifier": "involved_in", "term": "positive regulation of endothelial cell proliferation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0001944", "qualifier": "involved_in", "term": "vasculature development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0001945", "qualifier": "involved_in", "term": "lymph vessel development"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0001946", "pubmed": 19779139, "qualifier": "involved_in", "term": "lymphangiogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0001946", "qualifier": "involved_in", "term": "lymphangiogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0002040", "qualifier": "involved_in", "term": "sprouting angiogenesis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0003016", "qualifier": "involved_in", "term": "respiratory system process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007169", "pubmed": 10835628, "qualifier": "involved_in", "term": "cell surface receptor protein tyrosine kinase signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007275", "qualifier": "involved_in", "term": "multicellular organism development"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0008284", "pubmed": [7675451, 19779139], "qualifier": "involved_in", "term": "positive regulation of cell population proliferation"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0010575", "pubmed": 19779139, "qualifier": "involved_in", "term": "positive regulation of vascular endothelial growth factor production"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0010595", "pubmed": 11532940, "qualifier": "involved_in", "term": "positive regulation of endothelial cell migration"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0018108", "pubmed": 7898938, "qualifier": "involved_in", "term": "peptidyl-tyrosine phosphorylation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0030335", "qualifier": "involved_in", "term": "positive regulation of cell migration"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0033674", "qualifier": "involved_in", "term": "positive regulation of kinase activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035924", "pubmed": 9435229, "qualifier": "involved_in", "term": "cellular response to vascular endothelial growth factor stimulus"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0035924", "pubmed": 19779139, "qualifier": "involved_in", "term": "cellular response to vascular endothelial growth factor stimulus"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0038084", "pubmed": 23878260, "qualifier": "involved_in", "term": "vascular endothelial growth factor signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0043066", "pubmed": 11532940, "qualifier": "involved_in", "term": "negative regulation of apoptotic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0043408", "qualifier": "involved_in", "term": "regulation of MAPK cascade"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0043410", "pubmed": 19779139, "qualifier": "involved_in", "term": "positive regulation of MAPK cascade"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0046330", "pubmed": 16076871, "qualifier": "involved_in", "term": "positive regulation of JNK cascade"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0046777", "pubmed": [7675451, 9435229, 23878260], "qualifier": "involved_in", "term": "protein autophosphorylation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0048010", "qualifier": "involved_in", "term": "vascular endothelial growth factor receptor signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0048010", "pubmed": 9012504, "qualifier": "acts_upstream_of_or_within", "term": "vascular endothelial growth factor receptor signaling pathway"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0048010", "pubmed": [11532940, 19779139], "qualifier": "involved_in", "term": "vascular endothelial growth factor receptor signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048286", "qualifier": "involved_in", "term": "lung alveolus development"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0048514", "qualifier": "involved_in", "term": "blood vessel morphogenesis"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0060312", "qualifier": "involved_in", "term": "regulation of blood vessel remodeling"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0070374", "pubmed": 11532940, "qualifier": "involved_in", "term": "positive regulation of ERK1 and ERK2 cascade"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0090037", "pubmed": 11532940, "qualifier": "involved_in", "term": "positive regulation of protein kinase C signaling"}], "CC": [{"evidence": "IEA", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": 7898938, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0043235", "qualifier": "part_of", "term": "receptor complex"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0043235", "pubmed": 23382219, "qualifier": "part_of", "term": "receptor complex"}], "MF": [{"category": "MF", "evidence": "IMP", "id": "GO:0004714", "pubmed": 7898938, "qualifier": "enables", "term": "transmembrane receptor protein tyrosine kinase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0005021", "qualifier": "enables", "term": "vascular endothelial growth factor receptor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0005021", "pubmed": [9012504, 23878260], "qualifier": "enables", "term": "vascular endothelial growth factor receptor activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0005021", "pubmed": [11532940, 19779139], "qualifier": "enables", "term": "vascular endothelial growth factor receptor activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [16530705, 20224550, 21130043, 22939624, 23878260, 27991863, 35384245], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005524", "qualifier": "enables", "term": "ATP binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019838", "pubmed": 9435229, "qualifier": "enables", "term": "growth factor binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019903", "pubmed": 20826270, "qualifier": "enables", "term": "protein phosphatase binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0042803", "pubmed": 23878260, "qualifier": "enables", "term": "protein homodimerization activity"}]}, "homologene": {"genes": [[7955, 30121], [8364, 100493801], [9031, 395742], [9544, 716412], [9598, 462339], [9606, 2324], [9615, 481464], [9913, 338031], [10090, 14257], [10116, 114110]], "id": 7321}, "interpro": [{"desc": "Protein kinase domain", "id": "IPR000719", "short_desc": "Prot_kinase_dom"}, {"desc": "Serine-threonine/tyrosine-protein kinase, catalytic domain", "id": "IPR001245", "short_desc": "Ser-Thr/Tyr_kinase_cat_dom"}, {"desc": "Tyrosine-protein kinase, active site", "id": "IPR008266", "short_desc": "Tyr_kinase_AS"}, {"desc": "Protein kinase-like domain superfamily", "id": "IPR011009", "short_desc": "Kinase-like_dom_sf"}, {"desc": "Tyrosine-protein kinase, catalytic domain", "id": "IPR020635", "short_desc": "Tyr_kinase_cat_dom"}, {"desc": "Immunoglobulin-like domain", "id": "IPR007110", "short_desc": "Ig-like_dom"}, {"desc": "Immunoglobulin-like fold", "id": "IPR013783", "short_desc": "Ig-like_fold"}, {"desc": "Immunoglobulin-like domain superfamily", "id": "IPR036179", "short_desc": "Ig-like_dom_sf"}, {"desc": "Platelet-derived growth factor receptor-like protein", "id": "IPR042495", "short_desc": "PDGFRL"}, {"desc": "Tyrosine-protein kinase, receptor class III, conserved site", "id": "IPR001824", "short_desc": "Tyr_kinase_rcpt_3_CS"}, {"desc": "Immunoglobulin subtype 2", "id": "IPR003598", "short_desc": "Ig_sub2"}, {"desc": "Immunoglobulin subtype", "id": "IPR003599", "short_desc": "Ig_sub"}, {"desc": "Immunoglobulin I-set", "id": "IPR013098", "short_desc": "Ig_I-set"}, {"desc": "Immunoglobulin", "id": "IPR013151", "short_desc": "Immunoglobulin"}, {"desc": "Protein kinase, ATP binding site", "id": "IPR017441", "short_desc": "Protein_kinase_ATP_BS"}, {"desc": "VEGFR-2, transmembrane domain", "id": "IPR041348", "short_desc": "VEGFR-2_TMD"}], "ipi": ["IPI00293565", "IPI00337568", "IPI00966321", "IPI00968257"], "map_location": "5q35.3", "name": "fms related receptor tyrosine kinase 4", "other_names": ["Feline McDonough Sarcoma (FMS)-like tyrosine kinase 4", "VEGF receptor-3", "fms related tyrosine kinase 4", "fms-like tyrosine kinase 4", "primary congenital lymphedema", "tyrosine-protein kinase receptor FLT4", "vascular endothelial growth factor receptor 3"], "pantherdb": {"HGNC": "3767", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "95561", "ortholog_type": "LDO", "panther_family": "PTHR24416", "taxid": 10090, "uniprot_kb": "P35917"}, {"RGD": "621737", "ortholog_type": "LDO", "panther_family": "PTHR24416", "taxid": 10116, "uniprot_kb": "Q91ZT1"}, {"Ensembl": "ENSGALG00000005802", "ortholog_type": "LDO", "panther_family": "PTHR24416", "taxid": 9031, "uniprot_kb": "F1N871"}, {"ZFIN": "ZDB-GENE-980526-326", "ortholog_type": "LDO", "panther_family": "PTHR24416", "taxid": 7955, "uniprot_kb": "Q5MD89"}, {"FlyBase": "FBgn0032006", "ortholog_type": "O", "panther_family": "PTHR24416", "taxid": 7227, "uniprot_kb": "E1JHB7"}], "uniprot_kb": "P35916"}, "pathway": {"biocarta": [{"id": "no1pathway", "name": "actions of nitric oxide in the heart"}, {"id": "vegfpathway", "name": "vegf hypoxia and angiogenesis"}], "kegg": [{"id": "hsa04010", "name": "MAPK signaling pathway - Homo sapiens (human)"}, {"id": "hsa04014", "name": "Ras signaling pathway - Homo sapiens (human)"}, {"id": "hsa04015", "name": "Rap1 signaling pathway - Homo sapiens (human)"}, {"id": "hsa04020", "name": "Calcium signaling pathway - Homo sapiens (human)"}, {"id": "hsa04151", "name": "PI3K-Akt signaling pathway - Homo sapiens (human)"}, {"id": "hsa04510", "name": "Focal adhesion - Homo sapiens (human)"}, {"id": "hsa05200", "name": "Pathways in cancer - Homo sapiens (human)"}, {"id": "hsa05224", "name": "Breast cancer - Homo sapiens (human)"}], "pid": [{"id": "lymphangiogenesis_pathway", "name": "VEGFR3 signaling in lymphatic endothelium"}, {"id": "vegf_vegfr_pathway", "name": "VEGF and VEGFR signaling network"}], "reactome": [{"id": "R-HSA-157118", "name": "Signaling by NOTCH"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-194138", "name": "Signaling by VEGF"}, {"id": "R-HSA-194313", "name": "VEGF ligand-receptor interactions"}, {"id": "R-HSA-195399", "name": "VEGF binds to VEGFR leading to receptor dimerization"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}, {"id": "R-HSA-9013694", "name": "Signaling by NOTCH4"}, {"id": "R-HSA-9013695", "name": "NOTCH4 Intracellular Domain Regulates Transcription"}], "wikipathways": [{"id": "WP3932", "name": "Focal Adhesion-PI3K-Akt-mTOR-signaling pathway"}, {"id": "WP4172", "name": "PI3K-Akt signaling pathway"}, {"id": "WP4223", "name": "Ras signaling"}, {"id": "WP4262", "name": "Breast cancer pathway"}, {"id": "WP4331", "name": "Neovascularisation processes"}, {"id": "WP4540", "name": "Pathways Regulating Hippo Signaling"}, {"id": "WP4541", "name": "Hippo-Merlin Signaling Dysregulation"}]}, "pdb": ["4BSJ", "4BSK"], "pfam": ["PF00047", "PF07679", "PF07714", "PF17988", "PF21339"], "pharmgkb": "PA28183", "pharos": {"target_id": 14013, "tdl": "Tclin"}, "pir": "A48999", "prosite": ["PS50011", "PS50835"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF249491", "relationship": "is"}, {"id": "GNF249492", "relationship": "is"}, {"id": "GNF249493", "relationship": "is"}, {"id": "GNF249494", "relationship": "is"}], "GNF_hs-Origene": [{"id": "GNF043566", "relationship": "is"}, {"id": "GNF046558", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF082562", "relationship": "is"}, {"id": "GNF082563", "relationship": "is"}, {"id": "GNF082564", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF050990", "relationship": "is"}, {"id": "GNF055756", "relationship": "is"}, {"id": "GNF060435", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF062221", "relationship": "is"}, {"id": "GNF062222", "relationship": "is"}], "GNF_hs-pkinase_IDT-siRNA": [{"id": "GNF166780", "relationship": "is"}, {"id": "GNF166781", "relationship": "is"}, {"id": "GNF166782", "relationship": "is"}, {"id": "GNF166783", "relationship": "is"}], "Invitrogen_IVTHSSIPKv2": [{"id": "GNF323810", "relationship": "is"}, {"id": "GNF323811", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF339148", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF092986", "relationship": "is"}, {"id": "GNF132684", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000005.10", "NC_060929.1", "NG_011536.1"], "protein": ["NP_001341918.1", "NP_002011.2", "NP_891555.2", "XP_011532780.1", "XP_011532786.1", "XP_016864752.1", "XP_016864755.1", "XP_016864757.1", "XP_047272958.1", "XP_047272959.1", "XP_054208150.1", "XP_054208151.1", "XP_054208152.1", "XP_054208153.1", "XP_054208154.1", "XP_054208155.1", "XP_054208156.1"], "rna": ["NM_001354989.2", "NM_002020.5", "NM_182925.5", "XM_011534478.4", "XM_011534484.3", "XM_017009263.2", "XM_017009266.2", "XM_017009268.2", "XM_047417002.1", "XM_047417003.1", "XM_054352175.1", "XM_054352176.1", "XM_054352177.1", "XM_054352178.1", "XM_054352179.1", "XM_054352180.1", "XM_054352181.1"], "translation": [{"protein": "XP_016864757.1", "rna": "XM_017009268.2"}, {"protein": "NP_891555.2", "rna": "NM_182925.5"}, {"protein": "XP_047272958.1", "rna": "XM_047417002.1"}, {"protein": "XP_054208152.1", "rna": "XM_054352177.1"}, {"protein": "XP_054208153.1", "rna": "XM_054352178.1"}, {"protein": "XP_011532780.1", "rna": "XM_011534478.4"}, {"protein": "XP_047272959.1", "rna": "XM_047417003.1"}, {"protein": "XP_054208150.1", "rna": "XM_054352175.1"}, {"protein": "XP_054208155.1", "rna": "XM_054352180.1"}, {"protein": "XP_016864755.1", "rna": "XM_017009266.2"}, {"protein": "XP_016864752.1", "rna": "XM_017009263.2"}, {"protein": "NP_002011.2", "rna": "NM_002020.5"}, {"protein": "XP_054208156.1", "rna": "XM_054352181.1"}, {"protein": "XP_011532786.1", "rna": "XM_011534484.3"}, {"protein": "XP_054208151.1", "rna": "XM_054352176.1"}, {"protein": "XP_054208154.1", "rna": "XM_054352179.1"}, {"protein": "NP_001341918.1", "rna": "NM_001354989.2"}]}, "reporter": {"HG-U133_Plus_2": ["210316_at", "229902_at", "234379_at"], "HG-U95Av2": "403_s_at", "HG-U95B": "55409_at", "HTA-2_0": ["TC05002148.hg.1", "TC05003386.hg.1"], "HuEx-1_0": "2890756", "HuGene-1_1": "8116445", "HuGene-2_1": "17003958"}, "retired": 285682, "summary": "This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. [provided by RefSeq, Jul 2008].", "symbol": "FLT4", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1333569"}, "unigene": "Hs.646917", "uniprot": {"Swiss-Prot": "P35916", "TrEMBL": ["D6RFF2", "B5A927", "E9PD35"]}, "wikipedia": {"url_stub": "FLT4"}}